Labial agglutination in prepubescent girls: A review of etiology, diagnosis, and management

Pazhoor is an MD candidate at Texas Tech University Health Sciences Center in Lubbock, Texas. Byrd is an MD candidate at Texas Tech University Health Sciences Center in Amarillo, Texas. Rogers is an associate professor and vice-chairman of obstetrics and gynecology at Texas Tech University Health Sciences Center.

Background

Labial agglutination (LA) is defined as the partial or complete fusion of the labia minora and affects approximately 2% to 5% of prepubescent girls between 3 months and 6 years of age. Despite its benign nature, management varies widely, and limited caregiver understanding may delay care and contribute to recurrence.

Methods

A structured PubMed review of English-language articles evaluating LA in girls under 8 years old was conducted. Included studies consisted of case reports, retrospective studies, and review articles. Data on etiology, presentation, management, recurrence, and follow-up were extracted and synthesized qualitatively.

Results

LA is most commonly linked to hypoestrogenism and local irritation. Many cases are asymptomatic and resolve spontaneously, whereas symptomatic presentations are treated with topical estrogen, topical steroids, or barrier ointments. Procedural separation is reserved for refractory or severe cases. Recurrence is common, and caregiver education affects long-term management and follow-up. Practice patterns remain inconsistent, and long-term data are limited.

Conclusion

LA is usually benign and self-limited, but inconsistent management may lead to unnecessary interventions. A standardized, conservative, and education-focused approach could reduce recurrence and procedural distress.

Introduction

Labial agglutination (LA), also known as labial adhesion or synechia vulvae, is an acquired pediatric condition that involves the partial or complete fusion of the labia minora at the midline.¹ It primarily affects prepubescent girls, with reported prevalence ranging from 0.6% to 5%, most commonly between 1 and 2 years of age.²

In early childhood, naturally low estrogen levels leave the vulvar epithelium thin and fragile, making it more vulnerable to irritation and inflammation.³ About half of the patients are asymptomatic and diagnosed incidentally during routine exams. When symptoms do occur, they include dysuria, postvoid dribbling, altered urinary stream, or recurrent urinary tract infections caused by urine trapping behind the adhesions.²

Most cases of LA resolve spontaneously over time, especially with puberty and rising estrogen levels.⁴ Therefore, management is typically conservative. When treatment is indicated, topical estrogen or corticosteroids are effective first-line options, whereas manual or surgical separation is reserved for severe or refractory cases.⁴

Despite the benign nature of LA, considerable variation exists regarding treatment selection, duration of therapy, and follow-up recommendations.¹ Caregiver understanding remains a key but often underrecognized factor influencing treatment success and recurrence rates.⁵

This review focuses on practical, clinic-based management strategies for clinicians.

Etiology and pathophysiology

LA results from a combination of hypoestrogenism and local irritation.³

Low estrogen leads to a thin, nonkeratinized epithelium that is susceptible to trauma.3 Irritation from diaper dermatitis, soaps, wipes, or infection triggers inflammation and epithelial damage, followed by fusion during healing.^2,3

Common contributing factors include the following:

• Poor or excessive hygiene

• Vulvovaginitis (Escherichia coli, group A Streptococcus)⁶

• Chronic dermatologic conditions (atopic dermatitis, lichen sclerosus)⁶

Estrogen deficiency alone is insufficient for adhesion formation; local irritation is also needed.³

Clinical presentation

LA exists along a spectrum, ranging from small posterior adhesions to complete fusion, obscuring the introitus.¹ The degree of severity may range from thin, translucent adhesions to more dense or fibrotic adhesions, influencing symptom burden and management decisions.

Physical examination typically shows a thin, pale midline raphe between the fused labia minora.¹

Most patients are asymptomatic and diagnosed incidentally during routine examination.⁴ When symptoms occur, they may include the following:

• Urinary spraying or dribbling

• Postvoid dampness

• Recurrent urinary tract infections (UTIs)

• Vulvar irritation or itching²

Rarely, extensive adhesions may cause urinary retention.²

Red flags requiring further evaluation include the following:

• Recurrent or severe UTIs

• Dense adhesions in older children

• Hypopigmentation or fissures (lichen sclerosus)⁶

• Bleeding or concerns for trauma

Diagnosis

Diagnosis is made clinically through visual inspection.¹

• No routine laboratory work or imaging is required

• A gentle, nontraumatic exam is sufficient

• A history should assess urinary symptoms, irritation, hygiene practices, and prior treatments⁷

Differential diagnosis includes the following:

• Vulvovaginitis

• Lichen sclerosus

• Hymenal variants

• Foreign body or trauma

Imaging is rarely indicated and should be reserved for atypical presentations.¹

Management strategies

Management depends on symptoms and severity, with an emphasis on minimizing unnecessary intervention (Table 1).

Key treatment points

• Observation is the first line for asymptomatic patients, as most cases resolve spontaneously without intervention.⁴

• Topical estrogen is highly effective and is usually applied 1 to 2 times daily for 2 to 6 weeks.⁵ Separation rates are high, but recurrence remains common. Adverse events (eg, breast budding and pigmentation) are rare and reversible.

• Topical corticosteroids (eg, betamethasone) have similar efficacy and may be considered when estrogen is contraindicated or ineffective.^8,9

• Barrier ointments are essential for both treatment and prevention. Continued application after separation helps prevent recurrence and is often needed for several months.⁵

• Procedural separation should be reserved for severe cases (involving urinary obstruction, recurrent infections, or failed medical therapy).⁷ These procedures carry risks of pain, trauma, and recurrence, and should be performed with appropriate analgesia and follow-up.⁷

Caregiver education

Caregiver understanding strongly affects outcomes.^2,5

Common issues include the following:

• Improper application technique

• Early cessation of therapy

• Concerns about anatomy

Key teaching points include the following:

• Apply medication with a finger and gentle pressure⁵

• Continue barrier ointment for several months after separation⁵

• Avoid irritants (eg, soaps, wipes, and friction)²

Recurrence is often associated with early discontinuation of maintenance therapy or incorrect application technique. Demonstration of proper application methods during clinic visits may improve adherence and outcomes.

Caregivers may fear underlying congenital or structural abnormalities. Clear reassurance may enhance adherence and reduce unnecessary referrals.^7,9

Variability in clinical practice

Management varies due to a lack of standardized definitions and limited comparative data.^8,14 This can contribute to both overtreatment and delayed care.

Psychosocial considerations

Genital examinations can be distressing for children. Best practices include the following:

• Perform a gentle examination

• Ensure a caregiver is present

• Avoid unnecessary manipulation¹⁰

Procedural interventions should be limited to clear indications and performed with appropriate analgesia.⁷ Clinicians should emphasize that the condition is benign and that recurrence is common, not due to caregiver error.

Future directions

Key gaps include the following:

• Lack of standardized definitions (eg, severity, recurrence)¹³

• Limited prospective and comparative treatment studies^5,6

• Unclear optimal duration of topical therapy⁵

• Limited long-term outcome data⁴

• Variability across specialties^1,14

Opportunities for improvement include the following:

• Development of standardized clinical algorithms

• Creation of comparative trials (estrogen vs corticosteroids)

• Creation of caregiver education tools^5,6

• Incorporation of anticipatory guidance in routine pediatric care

Conclusion

Labial agglutination is a common, benign, and often self-resolving condition. Most cases require reassurance rather than intervention. When treatment is needed, topical therapies are effective, though recurrence is common.

Inconsistent management and limited caregiver understanding remain key challenges. A standardized, conservative, and education-focused approach may reduce unnecessary interventions and improve long-term outcomes.

REFERENCES

1. O’Keefe RJ, Compton SD, Dendrinos ML, Rosen MW. Management variation in pediatric labial adhesions: a retrospective cohort study. J Pediatr. 2025;281:114529. doi:10.1016/j.jpeds.2025.114529

2. Yang H, Shi Y, Ji G. Surgical management of near complete labia majora fusion without hymenal disruption. J Minim Invasive Gynecol. 2025;32(12):1040-1042.

3. Mohapatra I, Samantaray SR. Labial fusion recurrence in a prepubertal girl: a case report and review of literature. Cureus. 2022;14(6):e26059. doi:10.7759/cureus.26059

4. Günther V, Bauer M, Maass-Poppenhusen K, Maass N, Alkatout I. Pediatric and adolescent gynecology-a current overview. J Turk Ger Gynecol Assoc. 2023;24(1):65-73. doi:10.4274/jtgga.galenos.2022.2022-5-4

5. Goutham Krishna TC, Sagili H, Jayalakshmi D. Labial adhesions in a pre-pubertal girl: the importance of awareness. Trop Doct. 2021;51(4):661-662. doi:10.1177/00494755211020901

6. Gao H, Zhang Y, Pan Y, et al. Patterns of pediatric and adolescent female genital inflammation in China: an eight-year retrospective study of 49,175 patients in China. Front Public Health. 2023;11:1073886. doi:10.3389/fpubh.2023.1073886

7. Dhaiban MAR, Chaudhary MA. Manual separation of labial synechiae: a cost-effective method in prepubertal girls. Afr J Paediatr Surg. 2021;18(3):139-142. doi:10.4103/ajps.AJPS_34_20

8. Ahmed AH, Akoula AM, Fathy M. A combination of local corticosteroid and petroleum ointment in managing labial adhesions in prepubertal female children: should it be the first choice? Egypt J Surg. 2022;41(2):469-472. doi:10.4103/ejs.ejs_4_22

9. Illahi FR, Utama BI, Sari YM. Treatment of prepubertal labial adhesion with topical estriol: a case report. Authorea. Preprint posted online October 3, 2024.

10. Mitra S, Banerjee D, Chakrabarty D, Das S. Labial agglutination in different age groups: a case series. J Clin Diagn Res. 2022;16(5):QR01-QR04. doi:10.7860/JCDR/2022/51913.16325

11. Kim SW, Han JY, Han SJ, Kim H, Ku SY. Effect of topical estrogen cream compared with observation in prepubertal girls with labial adhesions. J Pediatr Urol. 2023;19(4):403.e1-403.e6. doi:10.1016/j.jpurol.2023.01.006

12. Wróblewska-Seniuk K, Jarząbek-Bielecka G, Kędzia W. Gynecological problems in newborns and infants. J Clin Med. 2021;10(5):1071. doi:10.3390/jcm10051071

13. Sabir S, Anand S, Mendez MD. Labial adhesions. In: StatPearls. StatPearls Publishing; 2023. Accessed July 7, 2026. https://www.ncbi.nlm.nih.gov/books/NBK470461/

14. Cosgrave EJ, Geraghty JM, Geoghegan AR. Identifying a knowledge deficit among pediatric and general practitioner trainees in pediatric and adolescent gynecology in an Irish hospital: a pilot study. J Pediatr Adolesc Gynecol. 2021;34(5):631-634. doi:10.1016/j.jpag.2021.01.012